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and Markus W. Büchler, MDObjectives: The aim of this study was to investigate the effect of pylorus
resection on postoperative delayed gastric emptying (DGE) after partial
pancreatoduodenectomy (PD).
Background: PD is the standard treatment for tumors of the pancreatic head.
Preservation of the pylorus has been widely accepted as standard procedure.
DGE is a common complication causing impaired oral intake, prolonged
hospital stay, and postponed further treatment. Recently, pylorus resection has
been shown to reduce DGE.
Methods: Patients undergoing PD for any indication at the University of
Heidelberg were randomized to either PD with pylorus preservation (PP) or
PD with pylorus resection and complete stomach preservation (PR). The
primary endpoint was DGE within 30 days according to the International
Study Group of Pancreatic Surgery definition.
Results: Ninety-five patients were randomized to PP and 93 patients to PR.
There were no baseline imbalances between the groups. Overall, 53 of 188
patients (28.2%) developed a DGE (grade: A 15.5%; B 8.8%; C 3.3%). In the
PP group 24 of 95 patients (25.3%) and in the PR group 29 of 93 patients
(31.2%) developed DGE (odds ratio 1.534, 95% confidence interval 0.788 to
2.987; P ¼ 0.208). Higher BMI, indigestion, and intraabdominal major
complications were significant risk factors for DGE.
Conclusions: In this randomized controlled trial, pylorus resection during PD
did not reduce the incidence or severity of DGE. The development of DGE
seems to be multifactorial rather than attributable to pyloric dysfunction alone.
Pylorus preservation should therefore remain the standard of care in PD. Copyright © 2017 Wolters Klu
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Reprints: Markus W. Büchler, MD, Department of General, Visceral, and Trans-
plantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120
Heidelberg, Germany. E-mail: markus.buechler@med.uni-heidelberg.de.
Copyright  2017 Wolters Kluwer Health, Inc. All rights reserved.
ISSN: 0003-4932/17/26706-1021
DOI: 10.1097/SLA.0000000000002480
Annals of Surgery  Volume 267, Number 6, June 2018Keywords: delayed gastric emptying, partial pancreatoduodenectomy,
postoperative complications, pylorus resection
(Ann Surg 2018;267:1021–1027)
P artial pancreatoduodenectomy (PD) is the standard treatment forbenign and malignant tumors of the pancreatic head and chronic
pancreatitis in this region.1,2 The historical standard procedure,
classic PD with resection of the distal stomach, was modified in
the 1970 s by Traverso and Longmire,3 who introduced preservation
of the pylorus. This modification has been shown in numerous
studies to be equivalent to classic PD with regard to tumor recurrence
and long-term survival.4 Pancreatic surgery has several specific
complications and recent developments in postoperative patient
management have led to continuous improvement in outcomes.5,6
One common complication after either method of PD is delayed
gastric emptying (DGE).7,8 DGE inhibits postoperative return to a
normal solid diet, impairs patients’ quality of life (QoL), and causes
delays in hospital discharge and in further adjuvant treatment.9 DGE
is believed to be a functional impairment of the physiological
propulsive action of the stomach and especially the pylorus. There-
fore, some patients react well to propulsive medication such as
erythromycin.10 In 2007, the International Study Group of Pancreatic
Surgery (ISGPS) proposed a standardized definition of DGE with 3
grades of severity, A to C.11 In an earlier retrospective analysis of
patients at the university of Heidelberg, the overall frequency of
DGE was 45%, comprising 28% DGE grade A, 8% grade B, and 9%
grade C.12
Several studies, including 2 randomized controlled trials, did
not demonstrate conclusive evidence for or against pylorus resec-
tion.13–16 Therefore, the aim of this trial was to investigate the effect
of pylorus resection on postoperative DGE in PD.METHODS
The PROPP study was a single-center, randomized, con-
trolled, patient- and observer-blinded trial (RCT) with 2 parallel
groups and a statistical superiority hypothesis (pylorus resection is
associated with less DGE than pylorus preservation). The study
protocol was approved by the Ethics Committee of the University
of Heidelberg, Germany, on May 17, 2012 (reference number S-121/
2012). The trial was registered with the World Health Organization
(WHO) network (German Clinical Trials Register DRKS00004191)
on June 29, 2012, and the final protocol was published with open
access.17 The trial was conducted at the Clinical Trial Center of the
Department of General, Visceral and Transplantation Surgery at the
University Hospital of Heidelberg. Data management and statistical
analysis was performed at the Institute of Medical Biometry andwer Health, Inc. All rights reserved.
Informatics (IMBI) of the University of Heidelberg. Monitoring was
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Harmonization of Technical Requirements for Registration of Phar-
maceuticals for Human Use E6 (Good Clinical Practice). The
introduction and the methods section are based on the published
protocol,13 which was published under a Creative Commons license
(http://creativecommons.org/licenses/by/4.0).
Patients
All patients scheduled for PD for any indication were eligible.
Further inclusion criteria were age equal to or older than 18 years and
written informed consent. The exclusion criteria were participation
in another interventional trial resulting in interference with the
intervention and/or outcome of this study, anticipated lack of com-
pliance, and language problems. Patients were informed about the
trial and the trial interventions and asked to participate. Patients
screened but not included in the trial were recorded in the screening
log with the reasons for nonenrollment.
Randomization and Blinding
All patients were randomized intraoperatively to 1 of the 2 groups
after the surgeon had confirmed that PD was feasible and preservation of
the pylorus technically and oncologically possible. Validated online
randomization software (randomizer.at: provided online by the Institute
for Medical Informatics, Statistics and Documentation, University of
Graz, Austria) was used for unstratified randomization with fixed
confidential block sizes in a 1:1 allocation ratio.
Patients were blinded to the intervention until discharge or
final assessment of the primary and secondary endpoints. Blinding of
the operating surgeon was not possible; however, the operating
surgeons were not involved in the assessment of outcomes. The
staff collecting data and assessing the endpoint were blinded to the
intervention during the whole trial. The data manager and statistician
were not blinded; however, they acted and evaluated data according
to a predefined analysis plan.
Interventions
In both groups, open partial PD was carried out and recon-
structed with an omega loop. A double-layer end-to-side pancrea-
ticojejunostomy and a monolayer end-to-side hepaticojejunostomy
were performed, all with 5/0 monofilament atraumatic single sutures.
In the control group, with preservation of the pylorus (PP), the
duodenum was divided 2 cm distal to the pylorus with a linear
stapling device, preserving the gastric vessels along the lesser and
the greater curvature. An antecolic end-to-side duodenojejunostomy
using 2-layer 4/0 monofilament atraumatic running sutures was
performed, approximately 50 cm distal to the hepaticojejunostomy.
No pyloric dilatation or pyloromyotomy was performed.
In the intervention group, with pylorus resection (PR), the
stomach was resected using a linear stapling device within 1 cm
proximal to the pyloric ring with complete preservation of the gastric
vessels along both curvatures to maintain perfusion of the distal
stomach via the gastroepiploic vessels and the left gastric artery,
respectively. An antecolic end-to-side gastrojejunostomy using 2-layer
4/0 monofilament atraumatic running sutures was performed, approx-
imately 50 cm distal to the hepaticojejunostomy (Fig. 1).
All interventions were performed by attendings of the
Department of General, Visceral, and Transplantation Surgery at the
University Hospital of Heidelberg in a standardized fashion. Adherence
was controlled by monitoring of the official operation report.
In both groups, the nasogastric tube (NGT) was removed as
soon as mechanical ventilation was stopped, usually at the end of the
operation. All patients were part of a fast-track concept and received
standardized oral nutrition and were supported with parenteral Copyright © 2017 Wolters Kluw
or enteral nutrition if oral uptake was not enough. Follow-up
1022 | www.annalsofsurgery.comexaminations were scheduled on postoperative days (POD) 7, 14
(or on the day of discharge, if earlier), and 30. The 30-day follow-up
visit was done by a telephone interview if the patient had already
been discharged.
Objectives and Outcomes
The objective of the PROPP study was to investigate whether
there is a difference in the rate of DGE between PP and PR within
30 days after operation. In a confirmatory analysis, the alternative
hypothesis of higher rates of DGE occurrence within 30 days after PP
than after PR was assessed.
The primary endpoint was DGE, as defined by the ISGPS,
within 30 days after the index operation. DGE was assessed as present
if the NGT had to be reinserted after the operation and was still in place
on or after POD 4. In accordance with the ISGPS definition, DGE was
assessed as grade A if the NGTwas inserted during the first postopera-
tive week but the patient returned to a solid oral diet before POD 14. For
DGE grade B, the NGTwas in place (still inserted or reinserted) during
postoperative week 2 but return to solid diet was achieved before POD
21. Patients assessed as suffering from DGE grade C needed a NGT
during the third week after operation. Solid oral intake was defined as
the first solid food in the course of standard care after pancreatic
surgery, for example, bread, rice, or fruit (not soup or rice porridge).
Gastric distension, vomiting, NGT insertion and removal dates, start of
solid food intake, medication with metoclopramide, erythromycin, and
strong oral laxatives, and diagnostic and interventional measures
because of DGE were assessed.
Secondary endpoints were operation time (time from incision
to skin closure in minutes), blood loss (estimated blood loss within
the suction system and on the surgical cloth measured in milliliters),
30-day mortality (death from any cause) and morbidity—that is,
postoperative pancreatic fistula (POPF),18 intraabdominal fluid col-
lection, chyle leak,19 postoperative hemorrhage, and pulmonary
aspiration and pneumonia and other complications as defined by
Dindo et al.20 In addition, reoperations and reinterventions were
captured because of complications [including computer tomography
(CT)-guided drainage], postoperative hospital stay in days (from day
of surgery to day of discharge), interventions because of DGE
(gastrography or endoscopy), medications because of nausea, vomit-
ing or DGE (metoclopramide, erythromycin, strong oral laxatives),
parenteral nutrition, and QoL on the day of the screening visit and
30 days after the operation (EORTC QLQ C30 and PAN26).
Sample Size
Based on existing evidence,12–16 the DGE rate was predicted
to be 32% in the PP group and 12% in the PR group. This meant that
89 patients had to be analyzed in each group to assure power of 90%
with the x2 test applied at a 2-sided level of significance of 5% in a
superiority setting. Ten more patients per group were added to
counteract the anticipated dropout. Therefore, enrollment stopped
after randomization of 198 patients.
Statistical Analysis
The analysis of the primary endpoint was based on the full
analysis set and followed the intention-to-treat (ITT) principle.
However, patients without follow up of the primary endpoint for
at least 21 days were excluded. The confirmatory analysis of the
primary endpoint was performed with a logistic regression model
including the covariables intervention, age, and BMI. In the pub-
lished protocol,17 surgeon experience was also considered as a factor
in the analysis of the primary endpoint; however, no interventions
were carried out by a nonboard-certified surgeon so this factor was
omitted. As a sensitivity analysis, the primary endpoint was alsoer Health, Inc. All rights reserved.
evaluated on the basis of the per protocol population. Any major
 2017 Wolters Kluwer Health, Inc. All rights reserved.
FIGURE 1. Standard reconstruction technique with a single loop and either pylorus preservation (duodeno-jejunostomy) or pylorus
resection (gastro-jejunostomy).
Annals of Surgery  Volume 267, Number 6, June 2018 Delayed Gastric Emptyingdeviation from the protocol led to exclusion of the patient from the
per protocol analysis set. For missing data, imputation was per-
formed by means of the ICA-r method described by Higgins et al.21
All analyses were performed using SAS version 9.4.
All secondary endpoints were analyzed descriptively based on
the ITT population. Exploratory data analysis was performed, with
calculation of appropriate summary measures for the empirical distri-
bution and of descriptive 2-sided P-values. In addition, we conducted a
univariable analysis of a potential association of DGE with baseline
characteristics (age, BMI, sex, weight loss, diabetes mellitus, exocrine
insufficiency, chronic renal insufficiency, COPD, ASA  III, and Copyright © 2017 Wolters Klu
indigestion) and early postoperative events (intraabdominal fluid
FIGURE 2. CONSORT flow diagram.
 2017 Wolters Kluwer Health, Inc. All rights reserved.collection, chyle leak, POPF, and major complications arising from
an intraabdominal focus, ie, POPF, SSI, and so on together). All
variables with P< 0.15 were evaluated in a multivariable model to
identify independent prognostic factors for DGE.
RESULTS
A total of 198 patients were randomized into the 2 interven-
tional groups between February 20, 2013 and June 10, 2016. With
10 patients excluded from analysis (Fig. 1), the ITT population
consisted of 188 patients (95 PP and 93 PR). Seventeen patients
had major protocol deviations, resulting in a per-protocol set of 171wer Health, Inc. All rights reserved.
patients. The CONSORT flow diagram is shown in Figure 2.
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patients in the PP group and 58 of 93 (62.4%) patients in the PR
TABLE 1. Baseline Data
N (%) or mean (SD) PP (n ¼ 95) PR (n ¼ 93) P
Sex
Male 55 (57.9%) 49 (52.7%) 0.473
Female 40 (42.1%) 44 (47.3%)
Age, yrs 62.9 (11.1) 63.8 (11.5) 0.568
BMI, kg/m2 26.2 (4.5) 24.8 (3.7) 0.051
Indigestion 18 (19.1%) 22 (23.7%) 0.452
Weight loss, kg 7.4 (5.0) 7.8 (5.6) 0.926
Diabetes mellitus 22 (23.2%) 15 (16.1%) 0.226
Exocrine insufficiency 7 (7.4%) 15 (16.1%) 0.062
Chronic renal insufficiency 3 (3.2%) 1 (1.1%) 0.322
COPD 4 (4.2%) 6 (6.5%) 0.494
ASA  III 40 (42.6%) 41 (44.1%) 0.559
Portal vein/superior mesenteric
vein involvement
22 (23.4%) 28 (31.1%) 0.240
Neoadjuvant chemotherapy 3 (3.2%) 8 (8.6%) 0.228
Histology
Pancreatic ductal adenocarcinoma 35 (36.8%) 45 (48.4%) 0.109
Intraductal papillary mucinous
neoplasia
22 (23.2%) 14 (15.0%) 0.158
Chronic pancreatitis 17 (17.9%) 20 (21.5%) 0.534
Other 21 (22.1%) 14 (15.1%) 0.169
ASA indicates American Society of Anesthesiologists; BMI, body mass index; PP,
preservation of the pylorus; PR, pylorus resection.
Categorical variables: x
2
test; continuous variables: Wilcoxon test.
TABLE 2. Primary and Secondary Endpoints
N % or mean (SD) PP (n ¼ 95) PR (n ¼ 93) P
Primary endpoint
DGE 24 (25.3%) 29 (31.2%) 0.367
Secondary endpoints
DGE grade A 13 (14.3%) 15 (16.7%) 0.489
DGE grade B 6 (6.6%) 10 (11.1%)
DGE grade C 2 (2.2%) 4 (4.4%)
Diagnostics procedures
because of DGE
14 (14.9%) 15 (16.1%) 0.815
Gastrography 8 (9.3%) 8 (9.4%) 0.980
Endoscopy 4 (4.7%) 7 (8.2%) 0.350
Other diagnostic procedures 5 (5.9%) 6 (7.1%) 0.755
Prokinetic medication 60 (63.2%) 58 (62.4%) 0.911
Metoclopramide 56 (58.9%) 52 (55.9%) 0.674
Erythromycin 11 (11.6%) 14 (15.1%) 0.483
Strong oral laxatives 15 (15.8%) 21 (22.6%) 0.237
Parenteral nutrition 30 (31.6%) 28 (30.1%) 0.827
Operation time, minutes 315.1 (71.5) 313.6 (73) 0.736
Intraoperative blood loss, mL 778.4 (662.1) 734.0 (533.3) 0.828
NGT removed immediately after OP 85 (89.5%) 87 (93.5%) 0.317
Total time NGT was inserted, days 2.6 (5.5) 2.5 (4.7) 0.529
Invasive interventions
because of complications
24 (24.2%) 18 (19.4%) 0.524
CT drainage 10 (10.5%) 8 (8.6%) 0.654
Reoperation 14 (14.7%) 10 (10.8%) 0.413
Postoperative hospital stay, days 15.4 (8.2) 14.1 (7.5) 0.112
Postoperative weight change, kg/day
y
0.2 (0.1) 0.1 (0.2) 0.556
CT indicates computer tomography; DGE, delayed gastric emptying; NGT,
nasogastric tube; PP, preservation of the pylorus; PR, pylorus resection.
Categorical variables: x
2
test; continuous variables: Wilcoxon test.
yUntil postoperative day 30.
TABLE 3. Postoperative Complications
N % or mean (SD) PP (n ¼ 95) PR (n ¼ 93) P
30-Day mortality 3 (3.2%) 2 (2.2%) 0.668
POPF
Biochemical leak 13 (13.7%) 11 (11.8%) 0.871
Grade B 9 (9.5%) 5 (5.4%) 0.428
Grade C 9 (9.5%) 4 (4.3%) 0.267
Intraabdominal fluid collection 29 (30.5%) 24 (25.8%) 0.472
Chyle leak 11 (11.6%) 12 (13.0%) 0.760
Postoperative hemorrhage 9 (9.5%) 9 (9.7%) 0.962
Pulmonary aspiration and pneumonia 6 (6.3%) 11 (11.8%) 0.188
Pulmonary embolism 2 (2.1%) 1 (1.1%) 0.573
Surgical site infection 6 (6.3%) 4 (4.3%) 0.538
Wound dehiscence 3 (3.2%) 2 (2.2%) 0.668
Categorical variables: x
2
test; continuous variables: Wilcoxon test.
POPF indicates postoperative pancreatic fistula; PP, preservation of the pylorus; PR,
pylorus resection.
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between the PP group and the PR group. Baseline data are shown in
Table 1.
Primary Endpoint
The DGE rate was 31.2% in the PR group (29 of 93 patients)
and 25.3% in the PP group (24 of 95 patients) (P ¼ 0.367). In the
confirmatory analysis correcting for BMI and age, no significant
difference of DGE rate was found between the 2 groups (odds ratio,
OR, 1.534, 95% confidence interval, CI, 0.788–2.987; P ¼ 0.208).
Similarly, the sensitivity analysis in the per-protocol set showed no
significant difference (OR 1.591, 95% CI 0.793–3.193; P¼ 0.191).
Most patients with DGE had grade A (28 of 188 patients; 15.5%),
followed by grade B (16 of 188 patients; 8.8%), and grade C (6 of
188 patients; 3.3%). The distribution of the DGE grades did not
differ significantly between PP and PR. Moreover, the total time in
days an NGT was inserted in both groups did not differ (PP: 2.6þ/–
5.5 vs PR: 2.5þ/–4.7; P¼ 0.529). Independently of the intervention
group, higher grades of DGE were associated with higher BMI
(mean BMI: no DGE, 25.1 kg/m2; DGE A, 26.5 kg/m2; DGE B,
26.8 kg/m2; DGE C, 27.0 kg/m2; P ¼ 0.039). These outcomes are
shown in Table 2.
Secondary Endpoints
Operating time did not differ between the 2 groups (PP:
315.1 min vs PR: 313.6 min; P ¼ 0.736). Blood loss was also not
different (PP: 778.4 mL vs PR: 734.0 mL; P ¼ 0.828). The 30-day
mortality was 2.7% (PP: 3 of 95 patients, 3.2% vs PR: 2 of 93
patients, 2.2%; P ¼ 0.668). Regarding postoperative complications,
POPF occurred in 27 of 188 patients (14.4%). The 2 groups showed
no significant difference in POPF (PP: 18 of 95 patients, 18.9% vs
PR: 9 of 93 patients, 9.7%; P ¼ 0.109). Intraabdominal fluid
collections were detected in 53 of 188 (28.2%) patients (PP: 29
of 95 patients, 30.5% vs PR: 24 of 93, 25.8%; P ¼ 0.472) and chyle
leak in 23 of 188 (12.3%) patients (PP: 11 of 95 patients, 11.6% vs Copyright © 2017 Wolters Kluw
PR: 12 of 93 patients, 13.0%; P ¼ 0.760). Postoperative hemorrhage
1024 | www.annalsofsurgery.comwas seen in 18 of 188 (9.6%) patients (PP: 9 of 95 patients, 9.5% vs
PR: 9 of 93 patients, 9.7%; P ¼ 0.962). An overview of all
postoperative complications is shown in Table 3. Overall, 40 of
188 (21.3%) patients needed at least one reintervention (reoperation
or CT-guided drainage); however, the rate of reintervention did not
differ significantly between the groups (PP: 22 of 95 patients, 23.2%
vs PR: 18 of 93 patients, 19.4%; P ¼ 0.524). No difference was seen
in patients’ length of hospital stay (PP: 15.4 days vs PR: 14.1 days;
P ¼ 0.112).
Diagnostic procedures because of DGE were performed in 29
of 188 (15.5%) patients, including gastrography (16 of 188 patients,
9.4%), endoscopy (11 of 188 patients, 6.5%), and other procedures
such as plain abdominal radiography or CT (11 of 188, 6.5%). There
were no differences in diagnostic procedures between the PP and PR
groups. Prokinetic medication was given in 60 of 95 (63.2%)er Health, Inc. All rights reserved.
 2017 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 4. Prognostic Factors for DGE
DGE No DGE Univariable Multivariable
Variable (n ¼ 53; 28.2%) (n ¼ 135; 71.8%) P OR (95% CI) P
Age (meanSD, yrs) 65.3 (10.3) 62.5 (11.5) 0.127 1.03 (0.99–1.07) 0.105
BMI (meanSD, kg/m2) 26.7 (4.8) 25.1 (3.8) 0.024 1.09 (1.01–1.19) 0.043
Female (n ¼ 84) 27 (50.9%) 57 (42.2%) 0.358 –
Weight loss (n ¼ 102) 33 (62.3%) 69 (51.1%) 0.106 2.07 (0.98–4.40) 0.057
PDAC (n ¼ 80) 22 (41.5%) 58 (43.0%) 0.828 –
Diabetes mellitus (n ¼ 37) 12 (22.6%) 25 (18.5%) 0.612 –
Exocrine insufficiency (n ¼ 22) 3 (5.7%) 19 (14.1%) 0.138 0.34 (0.08–1.39) 0.134
Chronic renal insufficiency (n ¼ 4) 2 (3.8%) 2 (1.5%) 0.321 –
COPD (n ¼ 10) 5 (9.4%) 5 (3.7%) 0.160 –
ASA  III (n ¼ 81) 27 (50.9%) 54 (40.0%) 0.246 –
Indigestion (n ¼ 40) 15 (28.3%) 25 (18.5%) 0.087 2.63 (1.07–6.46) 0.036
Intraabdominal fluid collection (n ¼ 16) 8 (15.1%) 8 (5.9%) 0.045 1.86 (0.51–6.75) 0.348
Chyle leak (n ¼ 18) 2 (3.8%) 16 (11.9%) 0.084 0.34 (0.07–1.71) 0.190
POPF (n ¼ 7) 5 (9.4%) 2 (1.5%) 0.010 3.30 (0.47–23.25) 0.231
Major abdominal complications 16 (30.2%) 14 (10.4%) 0.001 3.16 (1.32–7.54) 0.010
ASA indicates American Society of Anesthesiologists; BMI, body mass index; CI, confidence interval; COPD, chronic obstructive pulmonary disease; DGE, delayed gastric
emptying; OR, odds ratio; PDAC, pancreatic ductal adenocarcinoma; POPF, postoperative pancreatic fistula.
Categorical variables: x
2
test; continuous variables: Wilcoxon test.
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parenteral nutrition (PP: 30 of 95 patients, 31.6% vs PR: 28 of 93
patients, 30.1%; P ¼ 0.827).
Preoperatively, the patients’ QoL did not differ between the
groups. On POD 30, however, the QoL questionnaires showed
significant differences in 5 of 21 categories. Although fatigue, pain,
appetite, and diarrhea favored significantly PP, the domain ‘‘hepatic’’
was significantly better in the PR group. Thus, 4 of 5 categories
significantly favored the PP group on POD 30. Appendix 1 gives an
overview of QoL scores.
Regarding prognostic factors (Table 4), a multivariable anal-
ysis showed that higher BMI (OR 1.09, 95% CI 1.01–1.19, P ¼
0.043), the presence of preoperative indigestion (OR 2.63, 95% CI
1.07–6.46, P ¼ 0.036), and major abdominal complications (OR
3.16, 95% CI 1.32–7.54, P ¼ 0.010) were factors independently
associated with the occurrence of DGE.
DISCUSSION
The PROPP study did not detect a significant difference in DGE
rate within 30 days after PD between patients in whom the pylorus was
resected and those in whom it was preserved. With an overall rate of
28.2%, DGE remains a frequent and meaningful complication after
PD. The severity of DGE was also not influenced by the intervention,
as the distribution of DGE grades A to C did not differ between the PP
group and the PR group. A novel finding is the association between
BMI and DGE severity: patients with a higher BMI are more likely to
develop DGE, and DGE severity increases with increasing BMI.
Besides BMI, preoperative indigestion is a second independent risk
factor for development of DGE during the postoperative course. The
perioperative complications did not differ between PP and PR, so
safety is not a factor that needs to be taken into account when deciding
whether to preserve or resect the pylorus. Based on our findings, there
is no need to abandon the widely accepted strategy of pylorus
preservation after PD. The association of DGE with POPF alone could
not be confirmed. However, major intraabdominal complications were
strongly associated with the occurrence of DGE.
The findings of the PROPP study are in contrast with those of
most existing publications regarding the association of DGE and
pylorus resection. Most nonrandomized studies14,16,22–26 have con-
cluded that resection of the pylorus is favorable regarding DGE. In 2
13,27 Copyright © 2017 Wolters Klu
nonrandomized studies there was no difference between the 2
 2017 Wolters Kluwer Health, Inc. All rights reserved.techniques regarding DGE. A Japanese RCT15 included 64 patients
with PP and 66 patients with PR, with DGE between 7 days and
6 months postoperatively as endpoint. The observed frequency of
DGE was 17.2% for PP and 4.5% for PR (P ¼ 0.02). Another
Japanese RCT28 from 2014 found DGE rates of 20% in the PP group
and 12% in the PR group among a total of 100 patients, representing a
non-significant difference (P ¼ 0.414).
One can argue that the retrospective studies may have been
biased; however, the RCTs of Kawai et al15 and Matsumoto et al28
were of good quality. Therefore, there must be other reasons for the
difference in findings. A general difference between the populations
has to be assumed, as the overall DGE rate was 10.8% and 16% in the
previous RCTs and 28.2% in our RCT. There may be relevant genetic
differences between the Asian populations investigated in the earlier
studies and our mostly Caucasian population. The reconstruction
technique in the RCT of Matsumoto et al28 was retrocolic gastro-
enteric anastomosis. However, the impact of ante- or retrocolic
reconstruction on DGE is still under debate.29,30 Differences in
baseline characteristics are also possible, as the Asian populations
had lower BMI than the population of the PROPP study. Unfortu-
nately, BMI was not reported in the RCT of Kawai et al.15 However,
the preoperative weight of the Kawai cohort was reported as
55 10 kg, compared with 76.5 15.1 kg in the current RCT. In
the RCT by Matsumoto et al,28 where PR patients had a lower rate of
DGE, the overall cohort had a mean BMI of 21.7 kg/m2, compared
with 25.5 kg/m2 in the PROPP study. The hypothesis that BMI
influences DGE is supported by the fact that the PROPP study found
a significant association of higher BMI with higher grades of DGE.
Consequently, PR may still be beneficial in patients with lower BMI;
however, this remains to be investigated.
Furthermore, the common hypothesis is that DGE represents a
functional impairment of gastric motility and pyloric function, which
is supported by the observation that antecolic reconstruction of the
duodenojejunal passage significantly lowered DGE incidence, prob-
ably because of less chemical irritation from potential subclinical
leakage of the pancreatic anastomosis in the first few days after
operation. The additional anatomical modification represented by
removal of the pylorus would be expected to significantly enhance
this effect. However, this was not confirmed in the PROPP study. As
the multivariable analysis identified preoperative indigestion as anwer Health, Inc. All rights reserved.
independent risk factor for DGE, lack of preoperative stimulation of
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important pathophysiological mechanism. Therefore, the develop-
ment of DGE is likely to be multifactorial rather than attributable to
pyloric dysfunction alone. Consequently, our pathophysiological
understanding of DGE is not yet complete and additional strategies
to avoid DGE must be developed. Furthermore, as suggested by the
multivariable analysis, some instances of DGE may be because of
toxic intraabdominal sepsis.
Given the finding of no difference between PP and PR with
regard to DGE and other postoperative complications, one possible
conclusion is that both procedures can be widely used. However, the
potential long-term disadvantages of PR are as yet unknown. For
example, unimpeded reflux could lead to gastric stump cancer. Such
long-term problems may not be clinically relevant in pancreatic
cancer patients; in benign indications for PD, however, they may well
be. Therefore, pylorus preservation should remain the standard of
care in PD unless evidence accumulates to demonstrate the long-term
safety of pylorus resection.
The strengths and limitations of the PROPP study have to be
addressed. Sources of bias were reduced as far as possible by
multiple methodological measurements, and the risk of bias can
be considered low in all common domains.31,32
Moreover, negative trial results in the presence of a superiority
hypothesis should be interpreted cautiously. The PROPP study as-
sumed that PR would be associated with 20% less DGE than PP. In fact,
the effect in this study was opposite to the expected effect (PR tended to
have a higher DGE rate than PP). This results in a theoretical post hoc
power of 14% in a 2-sided superiority setting. This further implies that
the conclusion that both interventions are equivalent is not permitted
from a test for superiority. In other words, with a 6% difference of DGE
rate as cut-off, a total of 2400 patients would have been needed to show
equality. Consequently, the only valid interpretation of the data of the
PROPP study is the rejection of the alternative hypothesis (PR is
superior to PP). Furthermore, the study was conducted in a single-
center setting, which may reduce the generalizability of the findings to
high-volume pancreatic surgery centers.
CONCLUSIONS
In this RCT, pylorus resection during PD did not reduce the
incidence or severity of DGE. The development of DGE seems to be
multifactorial rather than attributable to pyloric dysfunction alone.
Pylorus preservation should therefore remain the standard of care in PD.
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APPENDIX 1. Quality
Mean (SD) PP (n ¼ 95)
Role functioning 31.6 (29.6)
Emotional functioning 59.0 (27.6)
Cognitive functioning 74.7 (28.4)
Social functioning 49.8 (32.6)






Appetite loss 51.3 (37.1)
Constipation 19.9 (31.2)
Diarrhea 24.7 (36.4)
Financial problems 22.8 (29.4)
Pancreatic pain 34.0 (23.6)
Digestive symptoms 58.2 (32.4)
Altered bowel habit 42.2 (30.4)
Hepatic 18.0 (24.1)
Body image 47.2 (33.8)
Satisfaction with health care 78.7 (26.6)
Sexuality 49.5 (38.6)
Wilcoxon-test.
", higher is better; #, lower is better.
 2017 Wolters Kluwer Health, Inc. All rights reserved.31. Probst P, Knebel P, Grummich K, et al. Industry bias in randomized controlled
trials in general and abdominal surgery: an empirical study. Ann Surg.
2016;264:87–92.
32. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of
Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collabora-
tion, 2011. Available at: www.handbook.cochrane.orgof life at POD 30
PR (n ¼ 93) P Direction
22.1 (24.3) 0.057 "
56.3 (25.9) 0.427 "
74.8 (22.9) 0.542 "
44.9 (31.7) 0.260 "
43.7 (19.1) 0.140 "
69.6 (22.2) 0.032 #
21.7 (27.5) 0.435 #
43.4 (31.9) 0.031 #
33.3 (29.4) 0.414 #
41.8 (30.7) 0.720 #
64.3 (36.7) 0.025 #
19.5 (31.8) 0.841 #
37.1 (37.4) 0.022 #
21.5 (33.3) 0.463 #
40.6 (23.8) 0.077 #
64.8 (29.0) 0.232 #
42.9 (32.3) 0.989 #
10.2 (17.5) 0.041 #
50.4 (32.7) 0.517 #
82.7 (24.8) 0.381 "
42.4 (41.3) 0.338 #wer Health, Inc. All rights reserved.
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